Cite
HARVARD Citation
Sun, Q. et al. (2021). FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor. International journal of cancer. 149 (3), pp. 657-674. [Online].